4//SEC Filing
SLOAN GAIL A 4
Accession 0001209191-10-000372
CIK 0000920465other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:14 PM ET
Size
6.1 KB
Accession
0001209191-10-000372
Insider Transaction Report
Form 4
SLOAN GAIL A
VP of Finance
Transactions
- Award
Restricted Stock Units
2009-12-31+483,810→ 483,810 total→ Common Stock (483,810 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of La Jolla Pharmaceutical Company common stock; award date value of common stock was $0.158 per share (the average of the closing prices of La Jolla Pharmaceutical Company's common stock for the five trading days following December 22, 2009).
- [F2]The restricted stock units vest upon the closing of La Jolla Pharmaceutical Company's proposed merger with Adamis Pharmaceuticals Corporation, subject to the continued employment of the reporting person through the closing date of the merger.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237523
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:14 PM ET
- Size
- 6.1 KB